WGU D027 Study Guide|158 Questions
With 100% Verified Answers.
Autosomal Dominant - Answer1 parent has, 50% change of child having
Autosomal Recessive - AnswerBoth parents are carriers, 25% change of child having,
50% chance child is a carrier.
Cystic Fibrosis - Answeraffects pancreas causing secretions in lungs
21st Trisomy - AnswerDown Syndrome
Klinefelter Syndrome (XXY) - Answermale has extra X, female like qualities
Turner Syndrome - AnswerMissing X in females
Alpha Thalassemia - Answerinherited blood disorder; mild to severe anemia
Beta Thallasemia - Answerlow hemoglobin; contraindicated medication ferrous sulfate
Prevalence Risk - Answerproportion of the population affected at a certain time
Incidence rate - Answernumber of new cases divided by population
Innate immunity - Answerinflammation; increased vascular permeability
B&T lymphocytes - Answerimmune response
primary malignant tumor - Answerlack of organization of cells
glucocorticoids - Answerused in combination with other agent to treat lymphoid tissue
(leukemia). glucocorticoids are directly toxic to lymphoid tissues.
Selective estrogen receptor modulators (SERM) - Answerfor hormone receptor
positive and advanced breast cancer. (Tamoxifin reduces risk and recurrence risk)
Heart failure - Answerimpairment of the ventricle to fill with or eject blood; heart
cannot meet metabolic need of the body.
, CHF - Answerheart cannot keep up with metabolic needs; volume overload in
pulmonary area
Left Ventricular Dysfunction - Answerreduced ejection fraction; ventricle having issue
ejecting blood.
normal ejection fraction - Answer55 - 60 % (blood pumped out with each heartbeat)
Ejection fraction of 50% - reduced or preserved? - Answerpreserved
Diastolic CHF - Answerpreserved ejection fraction, problem is with filling
Systolic CHF - Answerreduced ejection fraction, problem is with ejecting
Left sided CHF - Answerpulmonary (JVD, fluid volume overload, rails, S-3 murmurs)
** #1 cause of Right sided CHF
BNP - Answergold standard lab test to diagnose CHF
Echocardiogram - AnswerDiagnostic tool, evaluates heart structure and function
At Risk for HF - Stage A - Answerno structural heart disease or symptoms of heart
failure
Stage A HF co-morbidities - Answerhtn, atherosclerotic disease, diabetes, metabolic
syndrome, patients using cardiotoxins with family history
Therapy goals of stage A HF - Answertreat htn, encourage smoking cessation,
encourage regular exercise, treat lipid disorders, discourage alcohol intake/drug use,
control metabolic syndrome
Meds: ACEI or Angiotensin II RB for vascular disease or diabetes (avapro, losartan,
benicar, diovan, etc)
At Risk for HF - Stage B - Answerstructural heart disease but no symptoms of heart
failure
Stage B HF co-morbidities - Answerprevious MI, LV remodeling with LV hypertrophy
and low EF, asymptomatic valvular disease
Therapy goals of Stage B HF - AnswerMeds: ACEI or ARB, Beta-blockers, inplantable
defibrillators
Stage C heart failure - Answerstructural heart disease with prior or current symptoms
of HF
With 100% Verified Answers.
Autosomal Dominant - Answer1 parent has, 50% change of child having
Autosomal Recessive - AnswerBoth parents are carriers, 25% change of child having,
50% chance child is a carrier.
Cystic Fibrosis - Answeraffects pancreas causing secretions in lungs
21st Trisomy - AnswerDown Syndrome
Klinefelter Syndrome (XXY) - Answermale has extra X, female like qualities
Turner Syndrome - AnswerMissing X in females
Alpha Thalassemia - Answerinherited blood disorder; mild to severe anemia
Beta Thallasemia - Answerlow hemoglobin; contraindicated medication ferrous sulfate
Prevalence Risk - Answerproportion of the population affected at a certain time
Incidence rate - Answernumber of new cases divided by population
Innate immunity - Answerinflammation; increased vascular permeability
B&T lymphocytes - Answerimmune response
primary malignant tumor - Answerlack of organization of cells
glucocorticoids - Answerused in combination with other agent to treat lymphoid tissue
(leukemia). glucocorticoids are directly toxic to lymphoid tissues.
Selective estrogen receptor modulators (SERM) - Answerfor hormone receptor
positive and advanced breast cancer. (Tamoxifin reduces risk and recurrence risk)
Heart failure - Answerimpairment of the ventricle to fill with or eject blood; heart
cannot meet metabolic need of the body.
, CHF - Answerheart cannot keep up with metabolic needs; volume overload in
pulmonary area
Left Ventricular Dysfunction - Answerreduced ejection fraction; ventricle having issue
ejecting blood.
normal ejection fraction - Answer55 - 60 % (blood pumped out with each heartbeat)
Ejection fraction of 50% - reduced or preserved? - Answerpreserved
Diastolic CHF - Answerpreserved ejection fraction, problem is with filling
Systolic CHF - Answerreduced ejection fraction, problem is with ejecting
Left sided CHF - Answerpulmonary (JVD, fluid volume overload, rails, S-3 murmurs)
** #1 cause of Right sided CHF
BNP - Answergold standard lab test to diagnose CHF
Echocardiogram - AnswerDiagnostic tool, evaluates heart structure and function
At Risk for HF - Stage A - Answerno structural heart disease or symptoms of heart
failure
Stage A HF co-morbidities - Answerhtn, atherosclerotic disease, diabetes, metabolic
syndrome, patients using cardiotoxins with family history
Therapy goals of stage A HF - Answertreat htn, encourage smoking cessation,
encourage regular exercise, treat lipid disorders, discourage alcohol intake/drug use,
control metabolic syndrome
Meds: ACEI or Angiotensin II RB for vascular disease or diabetes (avapro, losartan,
benicar, diovan, etc)
At Risk for HF - Stage B - Answerstructural heart disease but no symptoms of heart
failure
Stage B HF co-morbidities - Answerprevious MI, LV remodeling with LV hypertrophy
and low EF, asymptomatic valvular disease
Therapy goals of Stage B HF - AnswerMeds: ACEI or ARB, Beta-blockers, inplantable
defibrillators
Stage C heart failure - Answerstructural heart disease with prior or current symptoms
of HF
